Pulse Biosciences, Inc.
PLSE
Kedudukan dalam Saham
#4269
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Harga Saham
$51.39
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$3.67B
Perubahan (1 hari)
1.09%
Perubahan (1 tahun)
197.94%
Negara
US
Perdagangan Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Sejarah harga saham bagi Pulse Biosciences, Inc. (PLSE)
Harga penutupan tertinggi: $49.20 pada 2026-10-01
Harga penutupan terendah: $4.20 pada 2016-05-01
Harga penutupan terendah: $4.20 pada 2016-05-01
Sejarah harga saham Pulse Biosciences, Inc. dari 2016 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 90.82% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $431.34 | -18.16% |
US
|
|
| $194.56 | -46.20% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $194.26 | 31.35% |
US
|
|
| $67.86 | -11.34% |
CH
|
